שולי רווח נקי ממכירות: Paragon 28, Inc. (FNA)

The Paragon 28, Inc. (FNA) implant ecosystem ensures total physician loyalty through unique surgical protocols. Strong pricing power is sustained by a vast catalog of specialized instruments, as evidenced by the current net profit margin illustrated in this chart by the GURU.Markets system; the parameter has stabilized at -21.30. Business growth is driven by joint educational programs with orthopedic surgeons and innovative developments.
paragon28.com (FNA) - פילוחי מדדים ודוחות פיננסיים

The market assesses the investment potential of Paragon 28, Inc. (FNA) through the business's ability to convert revenue into net income. This metric measures the remaining funds after deducting all operating and tax liabilities. By analyzing net profit per unit of revenue, an investor can gauge cost management efficiency. The production of highly specialized implants creates operating leverage, reducing unit costs as volumes grow. The asset belongs to the high-tech medical business class.